Home › NDC Lookup › RxCUI directory › RxCUI 198313

Triamterene 50 MG Oral Capsule — RxCUI 198313

RxNorm drug concept · Semantic clinical drug
RxCUI 198313 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198313
Official nameTriamterene 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped9
Package NDCs mapped11
Reported Medicaid activity (SDUD)1,245 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triamterene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Triamterene is a water pill — more specifically, a 'potassium-sparing' diuretic. It's used to reduce fluid buildup (edema) caused by conditions like congestive heart failure, liver...
  • Taking triamterene capsules after meals helps reduce the chance of stomach upset like nausea or vomiting. It's a simple step that makes the medication easier to tolerate day to day...
  • It's a real concern worth taking seriously. Triamterene keeps potassium in your body, which is helpful — but if potassium climbs too high, it can cause dangerous heart rhythm probl...
  • I've heard this medication can raise my potassium too high — should I be worried?
📖 Read our full Triamterene guide →

🕸️ Concept Web — How Triamterene 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Triamterene 50 MG Oral Capsule RxCUI 198313

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Triamterene 10763
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dyrenium 203238
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Triamterene Oral Capsule 374193
    • Triamterene Oral Product 1158234
    • Triamterene Pill 1158235
    • Triamterene Oral Capsule [Dyrenium] 366263
    • Dyrenium Oral Product 1170419
    • Dyrenium Pill 1170420
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Triamterene 50 MG SCDC · 316854
  • Triamterene Oral Capsule SCDF · 374193
  • Triamterene Oral Product SCDG · 1158234
  • Triamterene Pill SCDG · 1158235

Brand-Name Concepts

  • Triamterene 50 MG Oral Capsule [Dyrenium] SBD · 208675
  • Triamterene 50 MG [Dyrenium] SBDC · 569338
  • Triamterene Oral Capsule [Dyrenium] SBDF · 366263
  • Dyrenium Oral Product SBDG · 1170419
  • Dyrenium Pill SBDG · 1170420
  • Dyrenium BN · 203238

📦 FDA Products & Package NDCs

9 products · 11 package NDCs
11 package NDCs map to RxCUI 198313 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52817-0364-10 100 CAPSULE in 1 BOTTLE (52817-364-10) Triamterene TRUPHARMA LLC 2018-12-12
52817-0365-10 100 CAPSULE in 1 BOTTLE (52817-365-10) Triamterene TRUPHARMA LLC 2018-12-12
59212-0002-01 100 CAPSULE in 1 BOTTLE (59212-002-01) Dyrenium Advanz Pharma (US) Corp. 1999-10-01
59212-0003-01 100 CAPSULE in 1 BOTTLE (59212-003-01) Dyrenium Advanz Pharma (US) Corp. 1999-01-01
66993-0831-02 100 CAPSULE in 1 BOTTLE (66993-831-02) triamterene Prasco Laboratories 2019-08-13
66993-0832-02 100 CAPSULE in 1 BOTTLE (66993-832-02) Triamterene Prasco Laboratories 2019-08-13
70377-0138-11 30 CAPSULE in 1 BOTTLE (70377-138-11) Triamterene Biocon Pharma Inc. 2025-02-10
70377-0138-12 100 CAPSULE in 1 BOTTLE (70377-138-12) Triamterene Biocon Pharma Inc. 2025-02-10
70377-0139-11 30 CAPSULE in 1 BOTTLE (70377-139-11) Triamterene Biocon Pharma Inc. 2025-02-10
70377-0139-12 100 CAPSULE in 1 BOTTLE (70377-139-12) Triamterene Biocon Pharma Inc. 2025-02-10
72162-2265-01 100 CAPSULE in 1 BOTTLE (72162-2265-1) Triamterene Bryant Ranch Prepack 2026-03-18
Observed labelers: Biocon Pharma Inc. (4) · Advanz Pharma (US) Corp. (2) · Prasco Laboratories (2) · TRUPHARMA LLC (2) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.